Table Of Contents

1. Introduction 19
1.1. Objectives Of The Study 19
1.2. Market Definition 19
1.3. Overview Of Asia-Pacific Skin Graft Market 19
1.4. Currency And Pricing 20
1.5. Limitation 20
1.6. Markets Covered 21
2. Market Segmentation 23
2.1. Markets Covered 23
2.2. Geographic Scope 24
2.3. Years Considered For The Study 25
2.4. Currency And Pricing 25
2.5. Research Methodology 26
2.6. Primary Interviews With Key Opinion Leaders 29
2.7. Secondary Sources 30
2.8. Assumptions 30
3. Market Overview 31
3.1. Drivers 33
3.1.1. Increasing Number Of Burns Injuries, Pressure Ulcers And Skin Infections 33
3.1.2. Technological Advancements And Developments In Skin Grafting Techniques 34
3.1.3. Favorable Reimbursement Policies For Skin Grafting Procedure 35
3.2. Restraints 36
3.2.1. Side Effects Related To The Skin Graft Procedure 36
3.3. Opportunities 37
3.3.1. Increasing Medical Tourisms 37
3.4. Challenges 38
3.4.1. Competition Among Major Players 38
4. Executive Summary 39
5. Premium Insights 41
6. Asia-Pacific Skin Graft Market, By Type 44
6.1. Overview 45
6.2. Autologous 47
6.3. Isogeneic 48
6.4. Allogeneic 49
6.5. Xenogeneic 50
6.6. Prosthetic 51
7. Asia-Pacific Skin Graft Market, By Graft Thickness 52
7.1. Overview 53
7.2. Split-Thickness 55
7.3. Full-Thickness 56
7.4. Composite Graft 57
8. Asia-Pacific Skin Graft Market, By Application 58
8.1. Overview 59
8.2. Burns 61
8.3. Extensive Wound 62
8.4. Extensive Skin Loss Due To Infection 63
8.5. Skin Cancer 64
9. Asia-Pacific Skin Graft Market, By Equipment Type 65
9.1. Overview 66
9.2. Dermatome 68
9.2.1. Knife Dermatomes 70
9.2.1.1. Blair/Brown Knife 71
9.2.1.2. Watson Knife 71
9.2.1.3. Cobbett Knife 71
9.2.2. Drum Dermatomes 72
9.2.2.1. Padgett Dermatomes 72
9.2.2.2. Reese Dermatomes 73
9.2.3. Electrical Dermatomes 73
9.2.4. Air-Powdered Dermatomes 74
9.3. General Surgical Instruments 75
9.4. Consumables 76
9.5. Others 77
10. Asia-Pacific Skin Graft Market, By End User 78
10.1. Overview 79
10.2. Hospitals 81
10.3. Dermatology Clinics 82
10.4. Ambulatory Surgical Centers 83
11. Asia-Pacific Skin Graft Market, By Geography 84
11.1. Asia-Pacific 84
11.1.1. China 95
11.1.2. Japan 99
11.1.3. India 103
11.1.4. South Korea 107
11.1.5. Australia 111
11.1.6. Singapore 115
11.1.7. Thailand 119
11.1.8. Malaysia 123
11.1.9. Indonesia 127
11.1.10. Philippines 131
11.1.11. Rest Of Asia-Pacific 135
12. Asia-Pacific Skin Graft Market, Company Landscape 136
12.1. Company Share Analysis; Asia-Pacific 136
13. Company Profiles 137
13.1. Integra Lifesciences Corporation 137
13.1.1. Company Overview 137
13.1.2. Integra Lifesciences Corporation; Revenue Analysis 138
13.1.3. Product Portfolio 139
13.1.4. Recent Developments 140
13.2. Organogenesis Inc. 141
13.2.1. Company Overview 141
13.2.2. Organogenesis Inc.; Company Snapshot 141
13.2.3. Product Portfolio 142
13.2.4. Recent Developments 142
13.3. Zimmer Biomet 143
13.3.1. Company Overview 143
13.3.2. Zimmer Biomet; Revenue Analysis 143
13.3.3. Product Portfolio 144
13.3.4. Recent Developments 145
13.4. B. Braun Melsungen Ag 146
13.4.1. Company Overview 146
13.4.2. B. Braun Melsungen Ag; Revenue Analysis 146
13.4.3. Product Portfolio 147
13.4.4. Recent Developments 147
13.5. Avita Medical 148
13.5.1. Company Overview 148
13.5.2. Avita Medical; Revenue Analysis 148
13.5.3. Product Portfolio 149
13.5.4. Recent Developments 149
13.6. De Soutter Medical 150
13.6.1. Company Overview 150
13.6.2. De Soutter Medical; Company Snapshot 150
13.6.3. Product Portfolio 150
13.6.4. Recent Developments 150
13.7. Exsurco Medical, Inc. 151
13.7.1. Company Overview 151
13.7.2. Exsurco Medical, Inc.;Company Snapshot 151
13.7.3. Product Portfolio 152
13.7.4. Recent Developments 152
13.8. Mallinckrodt 153
13.8.1. Company Overview 153
13.8.2. Mallinckrodt; Revenue Analysis 153
13.8.3. Product Pipeline 154
13.8.4. Recent Developments 154
13.9. Nouvag 155
13.9.1. Company Overview 155
13.9.2. Nouvag; Company Snapshot 155
13.9.3. Product Portfolio 155
13.9.4. Recent Developments 155
13.10. Surtex Instruments Limited 156
13.10.1. Company Overview 156
13.10.2. Surtex Instruments Limited; Company Snapshot 156
13.10.3. Product Portfolio 157
13.10.4. Recent Developments 157
13.11. Tissue Regenix 158
13.11.1. Company Overview 158
13.11.2. Tissue Regenix; Revenue Analysis 158
13.11.3. Product Portfolio 159
13.11.4. Recent Developments 159
14. Related Reports 160